Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Cigna GroupWBO:CIGN +1.64%66 Debt-to-Equity is 0.73 as of Mar. 2026, which is 6% below its 10-year median of 0.78. GuruFocus rates WBO:CIGN with a GF Score™ of 66/100 and a GF Value™ of €369.89 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 15 Healthcare Plans companies, The Cigna Group ranks better than 53.33% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for The Cigna Group's Debt-to-Equity or its related term are showing as below:
WBO:CIGN'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.33 Med: 0.78 Max: 5.58
Current: 0.73
During the past 13 years, the highest Debt-to-Equity Ratio of The Cigna Group was 5.58. The lowest was 0.33. And the median was 0.78.
WBO:CIGN's Debt-to-Equity is ranked better than 53.33% of 15
companies
in the Healthcare Plans industry
Industry Median: 0.73
vs WBO:CIGN: 0.73
The Cigna Group (WBO:CIGN) Debt-to-Equity Explanation
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
The Cigna Group Debt-to-Equity Related Terms
The Cigna Group Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for The Cigna Group's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:CIGN vs ELV, HUM, CNC: Debt-to-Equity Comparison
For the Healthcare Plans subindustry, The Cigna Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cigna Group Debt-to-Equity vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, The Cigna Group's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where The Cigna Group's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Cigna Group (WBO:CIGN) has a Debt-to-Equity of 0.73 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on The Cigna Group and its competitors. This is near median its historical median of 0.78. Over the past decade, The Cigna Group's Debt-to-Equity has ranged from 0.33 to 5.58. According to the industry distribution chart, The Cigna Group ranks #7 out of 15 companies in the Healthcare Plans industry, placing it in the top 46.7%.
Is The Cigna Group's Debt-to-Equity too high?
The Cigna Group's current Debt-to-Equity of 0.73 is near median its 10-year median of 0.78. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 5.58. The Healthcare Plans industry median Debt-to-Equity is 0.73. The Cigna Group's value of 0.73 is 0% at this industry median. Based on the distribution chart, The Cigna Group ranks #7 out of 15 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, The Cigna Group has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cigna Group's Debt-to-Equity compare to ELV and HUM?
According to the Healthcare Plans industry distribution chart, The Cigna Group ranks #7 out of 15 companies for Debt-to-Equity. This puts The Cigna Group in the upper half of its industry. The industry median Debt-to-Equity is 0.73. The Cigna Group's value of 0.73 is 0% at this benchmark. Historically, The Cigna Group's own Debt-to-Equity has ranged from 0.33 to 5.58 over the past decade. While the company's 10-year median is 0.78 vs. the industry median of 0.73, The Cigna Group has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Plans company?
The median Debt-to-Equity among Healthcare Plans companies is 0.73, based on 15 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Cigna Group's current Debt-to-Equity of 0.73 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on The Cigna Group and its competitors. For the Healthcare Plans industry, the median Debt-to-Equity is 0.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Cigna Group's current Debt-to-Equity is 0.73, which is near median its own 10-year median of 0.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cigna Group stock overvalued right now?
Based on GuruFocus' analysis, The Cigna Group (WBO:CIGN) is currently considered Modestly Undervalued. The stock's GF Value™ is €369.89, compared to a current price of €266.40 — trading 28% below its estimated fair value. The current Debt-to-Equity is 0.73, which is near median its 10-year median of 0.78 and 0% at the Healthcare Plans industry median of 0.73. The Cigna Group's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For The Cigna Group (WBO:CIGN), the current Debt-to-Equity is 0.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Cigna Group (WBO:CIGN) Overvalued in 2026?
Based on GuruFocus' analysis, The Cigna Group stock appears to be undervalued.
The current stock price of €266.40 is trading 28% below its estimated GF Value™ of €369.89.
GuruFocus considers The Cigna Group to be Modestly Undervalued.
Key valuation signals for WBO:CIGN:
Debt-to-Equity: 0.73 (near median its 10-year median of 0.78)
GF Value™: €369.89 vs. price of €266.40 (28% below fair value)
Industry Position: 0% at the Healthcare Plans median (#7 of 15)
No single metric tells the full story. See the WBO:CIGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
66GF Score
Get the complete analysis for WBO:CIGN
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:CIGN has been successfully added to your 
